https://www.live-feeds.com/feed/moderna-raises-2026-outlook-as-ceo-says-newer-vaccines-are-gaining-tractionContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/moderna-raises-2026-outlook-as-ceo-says-newer-vaccines-are-gaining-tractionhttps://www.live-feeds.com/feed/moderna-raises-2026-outlook-as-ceo-says-newer-vaccines-are-gaining-traction#u195851Thu, 12 Nov 2026 03:38:46 +0000Moderna increased its full-year 2026 revenue growth forecast to 15%-25% from a previous target of up to 10% after reporting a surprise third-quarter profit. The revision reflects stronger-than-expected international COVID-19 vaccine sales and early traction for newly approved respiratory syncytial virus and combination vaccines. CEO Stephane Bancel said the newer products are gaining market share. The company beat Q3 earnings estimates, swinging to a profit on higher revenue.Why it mattersThe upgraded guidance signals a faster-than-anticipated transition from pandemic-era COVID boosters to a b